XML 26 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2017
Mar. 31, 2017
Mar. 31, 2016
ASSETS      
Cash and cash equivalents $ 31,206,495 $ 8,664,211 $ 9,270,010
Accounts receivable, net of allowance for doubtful accounts 5,423,618 5,506,472 3,392,941
Other receivables 806,148 464,085 581,213
Due from affiliates 0 18,314 20,505
Prepaid expenses and other current assets 282,732 269,168 293,828
Total current assets 37,718,993 14,922,250 13,558,497
Deferred financing costs, net   0 37,926
Property and equipment, net 1,167,680 1,205,139 1,247,973
Restricted cash 745,117 765,058 530,000
Intangible assets, net 1,822,542 1,904,269 2,353,212
Goodwill 1,622,483 1,622,483 1,622,483
Other assets 221,979 225,358 216,442
TOTAL ASSETS 43,298,794 20,644,557 19,566,533
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY      
Accounts payable and accrued liabilities 16,212,983 7,883,373 4,572,307
Medical liabilities 19,718,135 1,768,231 2,670,709
Convertible note payable, net of debt issuance cost 4,882,667 4,829,000 0
Lines of credit 25,000 62,500 188,764
Total current liabilities 40,838,785 14,543,104 7,431,780
Note payable - related party 5,000,000 5,000,000 0
Warrant liability   0 2,811,111
Deferred rent liability 715,462 747,418 728,877
Deferred tax liability 83,667 83,667 43,479
TOTAL LIABILITIES 46,637,914 20,374,189 11,015,247
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' (DEFICIT) EQUITY      
Common Stock Value 6,033 6,033 5,876
Additional paid-in capital 26,555,514 26,331,948 23,524,517
Accumulated deficit (41,266,193) (37,654,381) (28,684,565)
Stockholders’ deficit attributable to Apollo Medical Holdings, Inc. (3,742,123) (353,877) (1,269,427)
Non-controlling interest 403,003 624,245 2,742,935
Total stockholders' (deficit) equity (3,339,120) 270,368 1,473,508
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY 43,298,794 20,644,557 19,566,533
Series A Preferred Stock [Member]      
STOCKHOLDERS' (DEFICIT) EQUITY      
Preferred Stock Value 7,077,778 7,077,778 0
Total stockholders' (deficit) equity   7,077,778 0
Series B Preferred Stock [Member]      
STOCKHOLDERS' (DEFICIT) EQUITY      
Preferred Stock Value $ 3,884,745 3,884,745 3,884,745
Total stockholders' (deficit) equity   3,884,745 3,884,745
MEZZANINE | Series A Preferred Stock [Member]      
MEZZANINE EQUITY      
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B Preferred stock); 1,111,111 issued and outstanding as of March 31, 2016, Liquidation preference of $9,999,999 at March 31, 2016   $ 0 $ 7,077,778